Nisa Investment Advisors’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.74K | Buy |
1,357
+100
| +8% | +$718 | ﹤0.01% | 2279 |
|
|
2025
Q1 | $7.53K | Sell |
1,257
-106
| -8% | -$635 | ﹤0.01% | 2167 |
|
|
2024
Q4 | $10.6K | Buy |
1,363
+100
| +8% | +$780 | ﹤0.01% | 2120 |
|
|
2024
Q3 | $13.6K | Buy |
1,263
+53
| +4% | +$572 | ﹤0.01% | 2032 |
|
|
2024
Q2 | $10.2K | Buy |
1,210
+115
| +11% | +$969 | ﹤0.01% | 2147 |
|
|
2024
Q1 | $7.36K | Buy |
1,095
+40
| +4% | +$269 | ﹤0.01% | 2082 |
|
|
2023
Q4 | $6.2K | Sell |
1,055
-770
| -42% | -$4.53K | ﹤0.01% | 2103 |
|
|
2023
Q3 | $17.8K | Buy |
1,825
+771
| +73% | +$7.52K | ﹤0.01% | 2054 |
|
|
2023
Q2 | $12.5K | Buy |
1,054
+1,046
| +13,075% | +$12.4K | ﹤0.01% | 2220 |
|
|
2023
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 2560 |
|
|
2022
Q4 | $0 | Sell |
8
-42
| -84% | – | ﹤0.01% | 2601 |
|
|
2022
Q3 | $1K | Buy |
+50
| New | +$1K | ﹤0.01% | 2402 |
|